Information Journal Paper
APA:
Copy. (2017). Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling. BIOMEDICINE & PHARMACOTHERAPY, 96(-), 1109-1118. SID. https://sid.ir/paper/735111/en
Vancouver:
Copy. Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling. BIOMEDICINE & PHARMACOTHERAPY[Internet]. 2017;96(-):1109-1118. Available from: https://sid.ir/paper/735111/en
IEEE:
Copy, “Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling,” BIOMEDICINE & PHARMACOTHERAPY, vol. 96, no. -, pp. 1109–1118, 2017, [Online]. Available: https://sid.ir/paper/735111/en